Endothelin-converting enzyme inhibitors: current status and perspectives.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 10976788)

Published in J Cardiovasc Pharmacol on January 01, 2000

Authors

B M Löffler1

Author Affiliations

1: F. Hoffmann-La Roche Ltd, Pharma Division, Preclinical Research, Basel, Switzerland. bernd-m.loeffler@roche.com